Chronic Prostatitis Clinical Trial
Official title:
Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Study Protocol for a Randomized, Placebo-controlled Trial
NCT number | NCT02588274 |
Other study ID # | 2015S102 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 2015 |
Est. completion date | November 2017 |
Verified date | February 2019 |
Source | Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) affects many adult men worldwide. So far, available therapies offer little or no proven benefit to CP/CPPS. The investigators design and implement this study is to assess efficacy of acupuncture therapy performed in the CP/CPPS .
Status | Completed |
Enrollment | 68 |
Est. completion date | November 2017 |
Est. primary completion date | May 2017 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: 1. History of pain perceived in the region of the prostate and absence of other lower urinary tract pathology for a minimum of 3 out of the past 6 months. In addition, associated lower urinary tract symptoms, sexual function, psychological factors should be addressed. 2. Age 18 to 50 years 3. NIH Chronic Prostatitis Symptom Index (NIH-CPSI) total score= 15 (scale 0-43, and 0 means no symptom). Exclusion Criteria: 1. Other urologic disease (for example, acute prostatitis, bacterial prostatitis, benign prostatic hyperplasia, prostate cancer, urinary tuberculosis, urinary tract infection) 2. Serious or acute diseases with heart, liver, kidney and blood system. 3. Patients who had received acupuncture or medication (including alpha-blockers or pain killers) treatment in the week prior to the baseline assessment 4. Patients without telephone number who cannot be connected during the follow-up |
Country | Name | City | State |
---|---|---|---|
China | Guang'anmen Hospital, China Academy of Chinese Medical Science | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | NIH-CPSI total score and change from baseline | baseline, week 1-8 | ||
Secondary | NIH-CPSI subscales score | Baseline, week 4,8,20,32 | ||
Secondary | NIH-CPSI total score in follow-up | week 20,32 | ||
Secondary | IPSS total score and change from baseline | baseline, week 4,8,20,32 | ||
Secondary | Global response assessment improvement | week 4,8,20,32 | ||
Secondary | expectations degree | The expectations that acupuncture might help participants CP/CPPS at baseline. This scale includes two brief questions to investigate whether patients believe acupuncture treatment and if acupuncture may help CP/CPPS. The investigators designed this scale and the investigators want to explore the impact of variable that are potentially associated with placebo effects, namely will participants' expectations be treatment effect modifier? | baseline | |
Secondary | Degree of satisfaction | The investigators designed this scale, which include 5 grades answer from 0 to 4, means "not at all" "a little" "Quite satisfied" "satisfaction" "very satisfaction"and the investigators want to use this to test blinding of participants. | week 8,20,32 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02898220 -
Trans-MAPP II Study of Urologic Chronic Pelvin Pain
|
||
Recruiting |
NCT05868668 -
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
|
N/A | |
Withdrawn |
NCT03027076 -
Microbiome of Urologic Chronic Pelvic Pain Syndrome
|
N/A | |
Completed |
NCT00922012 -
Efficacy of Electromagnetic Stimulation Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome
|
N/A | |
Completed |
NCT00434343 -
Physical Therapy Trial for Pelvic Pain
|
N/A | |
Completed |
NCT05890235 -
Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
Phase 4 | |
Recruiting |
NCT03641807 -
Different Modes of Assessment on Acupuncture Effect on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
N/A | |
Recruiting |
NCT04976751 -
Real World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest China
|
Phase 1 | |
Recruiting |
NCT06299683 -
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
|
N/A | |
Completed |
NCT01843946 -
Clinical Efficacy of Roxithromycin in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
N/A | |
Terminated |
NCT00301405 -
Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain
|
Phase 2 | |
Not yet recruiting |
NCT06287970 -
TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS
|
N/A | |
Completed |
NCT01738464 -
Microbiomes of Pelvic Pain
|
||
Completed |
NCT03543761 -
Low-intensity Shockwave Therapy for Non-bacterial Prostatitis/Pelvic Pain Syndrome
|
N/A | |
Completed |
NCT02711943 -
Non Interventional Study of Levofloxacin in Chronic Prostatitis
|
N/A | |
Completed |
NCT04275297 -
Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome
|
N/A | |
Completed |
NCT02514265 -
Trans-MAPP Symptom Patterns Study (SPS)
|
||
Completed |
NCT05378646 -
Efficiency and Safety of the Drug Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Prostatitis
|
Phase 3 | |
Recruiting |
NCT04128280 -
Multi-center Clinical Observation of a New Treatment Method Based on the Pathogenesis of Obstructive Prostatitis
|
N/A | |
Recruiting |
NCT03629769 -
Effects of Proxelan Somministration in Patients With Chronic Prostatitis
|
Phase 3 |